SEC Info - Artemis Therapeutics, Inc. - ‘8-K’ for 6/30/22

SEC Info℠

Home

My Interests

Help

Please Sign In

Artemis Therapeutics, Inc. – ‘8-K’ for 6/30/22

On: Tuesday, 7/5/22, at 4:51pm ET · For: 6/30/22 · Accession #: 1178913-22-2584 · File #: 0-24431

Previous ‘8-K’: ‘8-K’ on 3/9/22 for 3/6/22 · Next: ‘8-K’ on 7/26/22 for 7/20/22 · Latest: ‘8-K’ on / for 5/22/23 · 12 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/05/22  Artemis Therapeutics, Inc.        8-K:1,2,3,5 6/30/22   21:2.4M                                   Z-K Global Ltd./FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML    251K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     49K 
                -- exhibit_4-1                                                   
 3: EX-10.2     Material Contract -- exhibit_10-2                   HTML     22K 
 4: EX-10.3     Material Contract -- exhibit_10-3                   HTML     36K 
 5: EX-10.4     Material Contract -- exhibit_10-4                   HTML     51K 
 6: EX-10.5     Material Contract -- exhibit_10-5                   HTML     24K 
 7: EX-10.6     Material Contract -- exhibit_10-6                   HTML     19K 
 8: EX-10.7     Material Contract -- exhibit_10-7                   HTML     24K 
 9: EX-21.1     Subsidiaries List -- exhibit_21-1                   HTML      9K 
10: EX-99.1     Miscellaneous Exhibit -- exhibit_99-1               HTML    418K 
11: EX-99.2     Miscellaneous Exhibit -- exhibit_99-2               HTML    341K 
12: EX-99.3     Miscellaneous Exhibit -- exhibit_99-3               HTML    210K 
16: R1          Document and Entity Information                     HTML     49K 
19: XML         IDEA XML File -- Filing Summary                      XML     16K 
17: XML         XBRL Instance -- form8k_htm                          XML     17K 
18: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
14: EX-101.LAB  XBRL Labels -- atms-20220630_lab                     XML     67K 
15: EX-101.PRE  XBRL Presentations -- atms-20220630_pre              XML     49K 
13: EX-101.SCH  XBRL Schema -- atms-20220630                         XSD     16K 
20: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    22K 
21: ZIP         XBRL Zipped Folder -- 0001178913-22-002584-xbrl      Zip    167K

Filing Submission 0001178913-22-002584 – SGML Text

Original SGML Text submitted by:	Z-K Global Ltd./FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 2.4M ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20220705-165214	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20220705-165211	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20220705-165127	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001178913-22-002584
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		29
<PERIOD>			20220630
<ITEMS>				1.01
<ITEMS>				2.01
<ITEMS>				2.02
<ITEMS>				3.02
<ITEMS>				5.01
<ITEMS>				5.02
<ITEMS>				5.03
<ITEMS>				5.06
<ITEMS>				9.01
<FILING-DATE>			20220705
<DATE-OF-FILING-DATE-CHANGE>	20220705

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Artemis Therapeutics, Inc.
<CIK>				0001062128
<ASSIGNED-SIC>			2890
<IRS-NUMBER>			841417774  ⇒ 84-1417774
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			000-24431
<FILM-NUMBER>			221065904
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			18 EAST 16TH STREET
<CITY>				NEW YORK
<STATE>				NY
<ZIP>				10003
<PHONE>				646-233-1454
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			18 EAST 16TH STREET
<CITY>				NEW YORK
<STATE>				NY
<ZIP>				10003
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		NEW YORK GLOBAL INNOVATIONS INC.
<DATE-CHANGED>			20140305
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		INKSURE TECHNOLOGIES INC.
<DATE-CHANGED>			20050401
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		INKSURE TECHNOLOGIES INC
<DATE-CHANGED>			19980519
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	form8k.htm
<DESCRIPTION>	8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:atms="http://artemis-therapeutics.com/20220630" xmlns="http://www.w3.org/1999/xhtml">
       Show <XBRL>: 6,157 lines (widest: 1,305 characters) - 426K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.1
<SEQUENCE>	2
<FILENAME>	exhibit_4-1.htm
<DESCRIPTION>	EXHIBIT 4.1
<TEXT>
<html>
       Show <HTML>: 419 lines (widest: 757 characters) - 66K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.2
<SEQUENCE>	3
<FILENAME>	exhibit_10-2.htm
<DESCRIPTION>	EXHIBIT 10.2
<TEXT>
<html>
       Show <HTML>: 346 lines (widest: 758 characters) - 29K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.3
<SEQUENCE>	4
<FILENAME>	exhibit_10-3.htm
<DESCRIPTION>	EXHIBIT 10.3
<TEXT>
<html>
       Show <HTML>: 541 lines (widest: 323 characters) - 54K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.4
<SEQUENCE>	5
<FILENAME>	exhibit_10-4.htm
<DESCRIPTION>	EXHIBIT 10.4
<TEXT>
<html>
       Show <HTML>: 741 lines (widest: 1,367 characters) - 72K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.5
<SEQUENCE>	6
<FILENAME>	exhibit_10-5.htm
<DESCRIPTION>	EXHIBIT 10.5
<TEXT>
<html>
       Show <HTML>: 280 lines (widest: 517 characters) - 32K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.6
<SEQUENCE>	7
<FILENAME>	exhibit_10-6.htm
<DESCRIPTION>	EXHIBIT 10.6
<TEXT>
<html>
       Show <HTML>: 191 lines (widest: 1,245 characters) - 20K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10.7
<SEQUENCE>	8
<FILENAME>	exhibit_10-7.htm
<DESCRIPTION>	EXHIBIT 10.7
<TEXT>
<html>
       Show <HTML>: 304 lines (widest: 543 characters) - 26K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-21.1
<SEQUENCE>	9
<FILENAME>	exhibit_21-1.htm
<DESCRIPTION>	EXHIBIT 21.1
<TEXT>
<html>
       Show <HTML>: 50 lines (widest: 232 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.1
<SEQUENCE>	10
<FILENAME>	exhibit_99-1.htm
<DESCRIPTION>	EXHIBIT 99.1
<TEXT>
<html>
       Show <HTML>: 4,714 lines (widest: 503 characters) - 578K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.2
<SEQUENCE>	11
<FILENAME>	exhibit_99-2.htm
<DESCRIPTION>	EXHIBIT 99.2
<TEXT>
<html>
       Show <HTML>: 3,613 lines (widest: 391 characters) - 455K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.3
<SEQUENCE>	12
<FILENAME>	exhibit_99-3.htm
<DESCRIPTION>	EXHIBIT 99.3
<TEXT>
<html>
       Show <HTML>: 2,931 lines (widest: 547 characters) - 336K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	13
<FILENAME>	atms-20220630.xsd
<DESCRIPTION>	XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 36 lines (widest: 587 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	14
<FILENAME>	atms-20220630_lab.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 105 lines (widest: 325 characters) - 23K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	15
<FILENAME>	atms-20220630_pre.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 75 lines (widest: 327 characters) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	16  ⇐ Not a Document/Exhibit
<FILENAME>	image0.jpg
<TEXT>
       Show <TEXT>: 2,206 lines (Unix-to-Unix encoding) - 134K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	17  ⇐ Not a Document/Exhibit
<FILENAME>	img101_v1.jpg
<TEXT>
       Show <TEXT>: 77 lines (Unix-to-Unix encoding) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	18  ⇐ Not a Document/Exhibit
<FILENAME>	img102_v1.jpg
<TEXT>
       Show <TEXT>: 40 lines (Unix-to-Unix encoding) - 3K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	19  ⇐ Not a Document/Exhibit
<FILENAME>	img103_v1.jpg
<TEXT>
       Show <TEXT>: 54 lines (Unix-to-Unix encoding) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	20  ⇐ Not a Document/Exhibit
<FILENAME>	img104_v1.jpg
<TEXT>
       Show <TEXT>: 194 lines (Unix-to-Unix encoding) - 12K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	21  ⇐ Not a Document/Exhibit
<FILENAME>	img105_v1.jpg
<TEXT>
       Show <TEXT>: 41 lines (Unix-to-Unix encoding) - 3K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	22  ⇐ Document/Exhibit 16
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 838 lines (widest: 391 characters) - 40K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	23  ⇐ Document/Exhibit 17
<FILENAME>	form8k_htm.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
       Show <XML>: 88 lines (widest: 111 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	24  ⇐ Document/Exhibit 18
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 131 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	25  ⇐ Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	26  ⇐ Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	27  ⇐ Document/Exhibit 19
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 59 lines (widest: 84 characters) - 3K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		JSON
<SEQUENCE>	30  ⇒ 28  ⇐ Document/Exhibit 20
<FILENAME>	MetaLinks.json
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 696 lines (widest: 316 characters) - 21K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	31  ⇒ 29  ⇐ Document/Exhibit 21
<FILENAME>	0001178913-22-002584-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 3,786 lines (Unix-to-Unix encoding) - 229K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001178913-22-002584 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Artemis Therapeutics, Inc. – ‘8-K’ for 6/30/22

On: Tuesday, 7/5/22, at 4:51pm ET · For: 6/30/22 · Accession #: 1178913-22-2584 · File #: 0-24431

Current Report — Form 8-KFiling Table of Contents

Current Report — Form 8-K

Filing Table of Contents